Ancillary Microbiome Collection From Mother/Infant Pairs During First Year of Life

February 28, 2019 updated by: Ian M. Paul, MD, Milton S. Hershey Medical Center
The investigators will be studying the development of the microbiome over the first year after birth in light of various environmental influences - e.g. mode of delivery, diet (and diet changes), antibiotic exposure, GERD medication exposure.

Study Overview

Status

Completed

Conditions

Detailed Description

Microbiome samples will be collected from mother/infant pairs during post-natal hospital stay through the first year of life. Investigators will perform statistical analyses to test the hypotheses (1) that there is an association between the developing oral and gut microbiomes, and (2) that they interact in affecting childhood obesity.

This study relates to the INSIGHT study (NCT01167270) and its last outcome measure; exploring oral and gut microbiome collected from that study's second born participants.

Study Type

Observational

Enrollment (Actual)

100

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Pennsylvania
      • Hershey, Pennsylvania, United States, 17033
        • Penn State Milton S Hershey Medical Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Healthy full-term mothers and infants delivering at the Penn State Milton S Hershey Medical center.

Description

Inclusion Criteria:

  1. full-term infant (> 36 0/7 weeks gestational age) without significant morbidity
  2. nursery/NICU/maternity stay of 7 days or less
  3. participant children can be (but do not have to be) twins
  4. English speaking mother
  5. care provided at an HMC affiliated clinic
  6. a working telephone number

Exclusion Criteria:

  1. prenatal ultrasound presence of intrauterine growth retardation (IUGR)
  2. infant birth weight <2250 grams
  3. presence of a congenital anomaly or neonatal condition that significantly affects a newborn's feeding (e.g. cleft lip, cleft palate, metabolic disease)
  4. any major maternal morbidities and/or pre-existing condition that would affect postpartum care or her ability to care for her newborn such as cancer, multiple sclerosis, lupus, etc.
  5. plan for newborn to be adopted
  6. plan to move from Central Pennsylvania within 1 year
  7. have 2 older siblings in INSIGHT/SIBSIGHT (NIH funded study related to this ancillary study)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Microbiome outcome
Time Frame: birth to 1 year
Microbiome diversity within individuals (how gut and oral microbiomes are similar or different) and between individuals
birth to 1 year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Genetic variation
Time Frame: birth to 1 year
Associations between genetic variation and microbiome diversity
birth to 1 year
Genetic variation
Time Frame: birth to 1 year
Genetic variation as it relates to growth outcomes
birth to 1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 17, 2017

Primary Completion (Actual)

December 15, 2017

Study Completion (Actual)

January 30, 2019

Study Registration Dates

First Submitted

July 25, 2017

First Submitted That Met QC Criteria

July 27, 2017

First Posted (Actual)

August 1, 2017

Study Record Updates

Last Update Posted (Actual)

March 4, 2019

Last Update Submitted That Met QC Criteria

February 28, 2019

Last Verified

February 1, 2019

More Information

Terms related to this study

Other Study ID Numbers

  • PRAMS034493EP

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Infant Development

Subscribe